Onera Health, one of the leaders in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG solution, now integrates with Somnoware by ResMed sleep lab management software. This integration enables clinicians to conduct Polysomnography tests (PSGs) where patients sleep most comfortably, in their own home, while managing the entire workflow in Somnoware.
“The integration with Somnoware is a welcome enhancement that broadens access to the Onera hPSG solution,” states Ruben de Francisco, Founder and CEO of Onera Health. “Many sleep centres are customers of both Onera and Somnoware. We are very pleased that the integration of our cloud-based platforms will enable clinicians to benefit from a streamlined clinical workflow while providing access to comprehensive sleep diagnostics, including web-based study review and reporting capabilities.”
Home polysomnography (hPSG) can address significant access challenges for patients who would benefit from PSG testing but instead drop out of the diagnostic pathway. These challenges are caused by the shortage of in-laboratory beds, technicians, and sleep physicians and have led to escalating costs and delayed diagnosis and treatment for many patients suffering from sleep disorders.
Now that Onera hPSG can be seamlessly incorporated into an existing Somnoware workflow, study results will be available in Somnoware for review, interpretation, and management as soon as the study is complete, eliminating the need for manual file transfers or switching between platforms. A more efficient workflow, combined with the benefits of a PSG study that is performed in the patient’s home, can increase access and convenience for patients while going beyond OSA detection by efficiently providing comprehensive diagnostic insights to sleep medicine physicians.
More related news:
Aesyra SA Completes Clinical Investigation for Dental and Sleep Disorders
Sleepypod Unveils Clickit Range Car Safety Harness for Dogs
HoneyNaps, an AI Sleep Technology Company, secures USD 11.6 million Series B investment
